{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-098909","form_type":"8-K","ticker":"TAOX","cik":"0001571934","company_name":"TAO Synergies Inc.","filed_at":"2025-10-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.788610+00:00","generated_at":"2026-05-17T03:53:47.438621+00:00","sec_items":["1.01","3.02","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"TAO Synergies raises $11M in private placement; terminates Alkon agreement; appoints Vice-Chairman","bullets":["Sold 11,000 Series E convertible preferred shares ($1,000 stated value) and warrants for 1.375M common shares at $8.00; $11M gross proceeds.","Investors include existing stockholders, James Altucher, and new strategic investor DCG; expected close Oct 15.","Proceeds for general corporate purposes and working capital, focusing on Bittensor (TAO) ecosystem investments.","Terminated consulting agreement with Dr. Daniel Alkon effective Oct 3; remains liable for incentive fees on Bryostatin transactions for one year.","Appointed Bruce Bernstein as Vice-Chairman of the Board effective Oct 1; William Singer remains independent director."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-098909","json":"https://secwatch.observer/filing/0001104659-25-098909.json","markdown":"https://secwatch.observer/filing/0001104659-25-098909.md","text":"https://secwatch.observer/filing/0001104659-25-098909.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1571934/000110465925098909/0001104659-25-098909-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1571934/000110465925098909/tm2528153d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:53:47.438621+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3381290b88f3f7fa4139eba6d39fec8efa101600","claim":"TAO Synergies Inc. issued 11,000 shares of the Company's newly designated Series E convertible preferred stock of preferred stock to certain accredited investors for aggregate gross proceeds...expected to be $11.0 million.","evidence_excerpt":"is expected to occur on October 15, 2025, subject to the satisfaction of customary closing conditions. The aggregate gross proceeds from the Private Placement are expected to be $11.0 million. The Company expects to use the net proceeds from the Private Placement for general corporate purposes and working capital. The Purchase Agreement contains certain","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465925098909/0001104659-25-098909-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"preferred stock"},{"label":"Shares","value":"11,000 shares of the Company's newly designated Series E convertible preferred stock"},{"label":"Purchaser","value":"certain accredited investors"},{"label":"Consideration","value":"aggregate gross proceeds...expected to be $11.0 million"}],"fact_type":"equity_issuance"},{"claim_id":"9180650295cbd18a1d36051b107fc90268660ed3","claim":"TAO Synergies Inc. issued warrants to purchase up to an aggregate of 1,375,000 shares of Common Stock of warrant to certain accredited investors for aggregate gross proceeds...expected to be $11.0 million.","evidence_excerpt":"is expected to occur on October 15, 2025, subject to the satisfaction of customary closing conditions. The aggregate gross proceeds from the Private Placement are expected to be $11.0 million. The Company expects to use the net proceeds from the Private Placement for general corporate purposes and working capital. The Purchase Agreement contains certain","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465925098909/0001104659-25-098909-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"warrant"},{"label":"Shares","value":"warrants to purchase up to an aggregate of 1,375,000 shares of Common Stock"},{"label":"Purchaser","value":"certain accredited investors"},{"label":"Consideration","value":"aggregate gross proceeds...expected to be $11.0 million"}],"fact_type":"equity_issuance"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}